Open AccessRituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children
Author(s) -
Véronique MinardColin,
Anne Aupérin,
Marta Pillon,
G.A. Amos Burke,
Donald A. Barkauskas,
Keith Wheatley,
Rafael F. Delgado,
Sarah Alexander,
Anne Uyttebroeck,
Catherine M. Bollard,
József Zsíros,
Monika Csóka,
Bernarda Kazanowska,
Aks Chiang,
Rodney R. Miles,
Andrew Wotherspoon,
Peter C. Adamson,
Gilles Vassal,
Catherine Patte,
Thomas G. Gross
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1915315
Subject(s) - rituximab , lymphoma , medicine , hodgkin lymphoma , b cell , oncology , cancer research , immunology , antibody
Rituximab added to chemotherapy prolongs survival among adults with B-cell cancer. Data on its efficacy and safety in children with high-grade, mature B-cell non-Hodgkin's lymphoma are limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom